Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

The radiobiological principles of boron neutron capture therapy: a critical review.

Hopewell JW, Morris GM, Schwint A, Coderre JA.

Appl Radiat Isot. 2011 Dec;69(12):1756-9. doi: 10.1016/j.apradiso.2011.04.019. Epub 2011 Apr 22. Review.

PMID:
21543233
2.
3.

Functional and histological changes in rat lung after boron neutron capture therapy.

Kiger JL, Kiger WS 3rd, Riley KJ, Binns PJ, Patel H, Hopewell JW, Harling OK, Busse PM, Coderre JA.

Radiat Res. 2008 Jul;170(1):60-9. doi: 10.1667/RR1266.1.

PMID:
18582158
4.

No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome.

Schuller BW, Rogers AB, Cormier KS, Riley KJ, Binns PJ, Julius R, Hawthorne MF, Coderre JA.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):205-10.

PMID:
17448874
5.

Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.

Crossley EL, Ziolkowski EJ, Coderre JA, Rendina LM.

Mini Rev Med Chem. 2007 Mar;7(3):303-13. Review.

PMID:
17346220
6.

Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival.

Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, van der Kogel AJ.

Radiat Res. 2006 Sep;166(3):495-503.

PMID:
16953668
7.

Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2006 Jun 15;12(12):3792-802.

8.

Depletion of neural precursor cells after local brain irradiation is due to radiation dose to the parenchyma, not the vasculature.

Otsuka S, Coderre JA, Micca PL, Morris GM, Hopewell JW, Rola R, Fike JR.

Radiat Res. 2006 May;165(5):582-91.

PMID:
16669713
9.

Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells.

Schuller BW, Binns PJ, Riley KJ, Ma L, Hawthorne MF, Coderre JA.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3787-92. Epub 2006 Feb 27.

10.

A bystander effect in alpha-particle irradiations of human prostate tumor cells.

Wang R, Coderre JA.

Radiat Res. 2005 Dec;164(6):711-22.

PMID:
16296877
11.

The MIT user center for neutron capture therapy research.

Harling OK, Riley KJ, Binns PJ, Patel H, Coderre JA.

Radiat Res. 2005 Aug;164(2):221-9.

PMID:
16038593
12.

Boron neutron capture therapy of cancer: current status and future prospects.

Barth RF, Coderre JA, Vicente MG, Blue TE.

Clin Cancer Res. 2005 Jun 1;11(11):3987-4002. Review.

13.

Differential oxidation of deoxyribose in DNA by gamma and alpha-particle radiation.

Collins C, Zhou X, Wang R, Barth MC, Jiang T, Coderre JA, Dedon PC.

Radiat Res. 2005 Jun;163(6):654-62.

PMID:
15913397
14.

Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model.

Horkan C, Dalal K, Coderre JA, Kiger JL, Dupuy DE, Signoretti S, Halpern EF, Goldberg SN.

Radiology. 2005 Apr;235(1):81-8. Epub 2005 Feb 24.

PMID:
15731375
15.

Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa.

Morris GM, Coderre JA, Micca PL, Nawrocky MM, Hopewell JW, Miura M.

Radiat Res. 2005 Jan;163(1):72-8.

PMID:
15606309
16.

Tolerance of normal human brain to boron neutron capture therapy.

Coderre JA, Hopewell JW, Turcotte JC, Riley KJ, Binns PJ, Kiger WS 3rd, Harling OK.

Appl Radiat Isot. 2004 Nov;61(5):1083-7.

PMID:
15308196
17.

Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.

Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):981-5.

PMID:
15308179
18.

Effects of boron neutron capture irradiation on the normal lung of rats.

Kiger JL, Kiger WS, Patel H, Binns PJ, Riley KJ, Hopewell JW, Harling OK, Coderre JA.

Appl Radiat Isot. 2004 Nov;61(5):969-73.

PMID:
15308177
19.

The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.

Morris GM, Micca PL, Coderre JA.

Appl Radiat Isot. 2004 Nov;61(5):917-21.

PMID:
15308168
20.

Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.

Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):899-903.

PMID:
15308165
21.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):267-77.

PMID:
14697448
22.

Comparison study of oxygen-induced MRI-signal changes and pO2 changes in murine tumors.

Weissfloch L, Peller M, Weber J, Feldmann HJ, Senekowitsch-Schmidtke R, Tempel K, Coderre JA, Molls M, Reiser M.

Adv Exp Med Biol. 2003;530:461-5.

PMID:
14562741
23.

Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.

Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd.

Technol Cancer Res Treat. 2003 Oct;2(5):355-75. Review.

PMID:
14529302
24.

Microdosimetric intercomparison of BNCT beams at BNL and MIT.

Burmeister J, Riley K, Coderre JA, Harling OK, Ma R, Wielopolski L, Kota C, Maughan RL.

Med Phys. 2003 Aug;30(8):2131-9.

PMID:
12945978
25.

Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.

Barth RF, Yang W, Coderre JA.

J Neurooncol. 2003 Mar-Apr;62(1-2):61-74. Review.

PMID:
12749703
26.

Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.

Morris GM, Coderre JA, Hopewell JW, Micca PL, Nawrocky M, Miura M.

Int J Radiat Biol. 2003 Mar;79(3):149-58.

PMID:
12745879
27.

Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.

Kreimann EL, Miura M, Itoiz ME, Heber E, Garavaglia RN, Batistoni D, Rebagliati RJ, Roberti MJ, Micca PL, Coderre JA, Schwint AE.

Arch Oral Biol. 2003 Mar;48(3):223-32.

PMID:
12648560
28.

Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.

Morris GM, Micca PL, Nawrocky MM, Weissfloch LE, Coderre JA.

Radiat Res. 2002 Dec;158(6):743-52.

PMID:
12452777
29.

Boron microquantification in oral muscosa and skin following administration of a neutron capture therapy agent.

Kiger WS 3rd, Micca PL, Morris GM, Coderre JA.

Radiat Prot Dosimetry. 2002;99(1-4):409-12.

PMID:
12194342
31.

The combination of X-ray-mediated radiosurgery and gene-mediated immunoprophylaxis for advanced intracerebral gliosarcomas in rats.

Smilowitz HM, Coderre JA, Nawrocky MM, Tu W, Pinkerton A, Jahng GH, Gebbers N, Slatkin DN.

J Neurooncol. 2002 Mar;57(1):9-18.

PMID:
12125969
32.

Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.

Cancer Res. 2002 Jun 1;62(11):3159-66.

33.

Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.

Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML, Nawrocky MM, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):858-68.

PMID:
11849812
34.
35.

Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm.

Miura M, Joel DD, Smilowitz HM, Nawrocky MM, Micca PL, Hoch DA, Coderre JA, Slatkin DN.

J Neurooncol. 2001 Apr;52(2):111-7.

PMID:
11508810
36.

Boron neutron capture therapy: effects of split dose and overall treatment time.

Morris GM, Micca PL, Rezvani M, Hopewell JW, Coderre JA.

J Neurooncol. 2001 Apr;52(2):101-10.

PMID:
11508809
37.

Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin.

Miura M, Morris GM, Micca PL, Lombardo DT, Youngs KM, Kalef-Ezra JA, Hoch DA, Slatkin DN, Ma R, Coderre JA.

Radiat Res. 2001 Apr;155(4):603-10.

PMID:
11260662
38.

A conducting plastic simulating brain tissue.

Burmeister J, Kota C, Maughan RL, Spokas JJ, Coderre JA, Ma R, Wielopolski L.

Med Phys. 2000 Nov;27(11):2560-4.

PMID:
11128308
39.

Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.

Ryynänen PM, Kortesniemi M, Coderre JA, Diaz AZ, Hiismäki P, Savolainen SE.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1145-54.

PMID:
11072174
40.

Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine.

Coderre JA, Gavin PR, Capala J, Ma R, Morris GM, Button TM, Aziz T, Peress NS.

J Neurooncol. 2000 May;48(1):27-40.

PMID:
11026694
41.

Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange.

Landis CS, Li X, Telang FW, Coderre JA, Micca PL, Rooney WD, Latour LL, Vétek G, Pályka I, Springer CS Jr.

Magn Reson Med. 2000 Oct;44(4):563-74. Erratum in: Magn Reson Med 2002 Aug;48(2):410.

42.

Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.

Yang W, Barth RF, Bartus RT, Rotaru JH, Moeschberger ML, Ferketich AK, Nawrocky MM, Coderre JA, Goodman JH.

Neurosurgery. 2000 Jul;47(1):189-97; discussion 197-8.

PMID:
10917362
43.

The combination of boron neutron-capture therapy and immunoprophylaxis for advanced intracerebral gliosarcomas in rats.

Smilowitz HM, Micca PL, Nawrocky MM, Slatkin DN, Tu W, Coderre JA.

J Neurooncol. 2000;46(3):231-40.

PMID:
10902854
44.

Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.

Smilowitz HM, Joel DD, Slatkin DN, Micca PL, Nawrocky MM, Youngs K, Tu W, Coderre JA.

J Neurooncol. 2000;46(3):193-203.

PMID:
10902851
45.

Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.

Morris GM, Coderre JA, Micca PL, Lombardo DT, Hopewell JW.

Br J Radiol. 2000 Apr;73(868):429-34.

PMID:
10844870
46.

Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.

Morris GM, Smith DR, Patel H, Chandra S, Morrison GH, Hopewell JW, Rezvani M, Micca PL, Coderre JA.

Br J Cancer. 2000 Jun;82(11):1764-71.

47.

Boron neutron capture therapy for malignant gliomas.

Diaz AZ, Coderre JA, Chanana AD, Ma R.

Ann Med. 2000 Feb;32(1):81-5. Review.

PMID:
10711581
48.

Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.

Schinazi RF, Hurwitz SJ, Liberman I, Juodawlkis AS, Tharnish P, Shi J, Liotta DC, Coderre JA, Olson J.

Clin Cancer Res. 2000 Feb;6(2):725-30.

49.

Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro.

Wittig A, Sauerwein WA, Coderre JA.

Radiat Res. 2000 Feb;153(2):173-80.

PMID:
10629616
50.

Supplemental Content

Loading ...
Support Center